<--- Back to Details
First PageDocument Content
Eye / Clinical pharmacology / Medical prescription / Patient safety / Vitreomacular adhesion / Macular hole / Macular degeneration / Macula of retina
Date: 2015-07-10 08:30:48
Eye
Clinical pharmacology
Medical prescription
Patient safety
Vitreomacular adhesion
Macular hole
Macular degeneration
Macula of retina

SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) ® JETREA ocriplasmin 2.5 mg/ml Pharmaceutical Services Department of Health and Community Services

Add to Reading List

Source URL: www.health.gov.nl.ca

Download Document from Source Website

File Size: 174,24 KB

Share Document on Facebook

Similar Documents